In response: Commentary on clinical significance of CYP2C9-status-guided valproic acid therapy in children.

dc.contributor.author	Monostory Katalin
dc.contributor.author	Bűdi Tamás
dc.contributor.author	Tóth Katalin
dc.contributor.author	Nagy Andrea
dc.contributor.author	Szever Zsuzsa
dc.contributor.author	Kiss Ádám Ferenc
dc.contributor.author	Temesvári Manna
dc.contributor.author	Háfra Edit
dc.contributor.author	Tapodi Adrienn
dc.contributor.author	Garami Miklós
dc.date.accessioned	2017-06-27T08:59:55Z
dc.date.available	2017-06-27T08:59:55Z
dc.date.issued	2016
dc.identifier	84985019845
dc.identifier.citation	pagination=1339-1340; journalVolume=57; journalIssueNumber=8; journalTitle=EPILEPSIA;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/4201
dc.identifier.uri	doi:10.1111/epi.13451
dc.relation.ispartof	urn:issn:0013-9580
dc.title	In response: Commentary on clinical significance of CYP2C9-status-guided valproic acid therapy in children.
dc.type	Journal Article
dc.date.updated	2017-03-31T07:50:22Z
dc.language.rfc3066	en
dc.identifier.mtmt	3104965
dc.identifier.wos	000380750300026
dc.identifier.pubmed	27485380
dc.contributor.department	SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem